Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5

Lake Street analyst Frank Takkinen has initiated coverage on Envoy Medical (NASDAQ: COCH) with a Buy rating. The firm has set a price target of $2.50 for the stock.